Macrophages reprogramming driven by cancer-associated fibroblasts under FOLFIRINOX treatment correlates with shorter survival in pancreatic cancer

Abstract Background Pancreatic ductal adenocarcinoma (PDAC) remains a clinically challenging cancer, mainly due to limited therapeutic options and the presence of a highly prominent tumor microenvironment (TME), facilitating tumor progression. The TME is predominated by heterogeneous populations of...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Principais autores: Zainab Hussain, Thomas Bertran, Pascal Finetti, Eugénie Lohmann, Émilie Mamessier, Ghislain Bidaut, François Bertucci, Moacyr Jesus Barreto de Melo Rêgo, Richard Tomasini
Formato: Artigo
Idioma:Inglês
Publicado em: 2024
Acesso em linha:https://doi.org/10.1186/s12964-023-01388-7
https://biosignaling.biomedcentral.com/counter/pdf/10.1186/s12964-023-01388-7
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!